User profiles for G. G. Einarsson
Gisli EinarssonQueen's University Belfast Verified email at qub.ac.uk Cited by 1900 |
Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation
MM Tunney, GG Einarsson, L Wei, M Drain… - American journal of …, 2013 - atsjournals.org
Rationale: Characterization of bacterial populations in infectious respiratory diseases will
provide improved understanding of the relationship between the lung microbiota, disease …
provide improved understanding of the relationship between the lung microbiota, disease …
[HTML][HTML] Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary disease
…, CJ Fong, W Ibrahim, G Brady, GG Einarsson… - Journal of Allergy and …, 2018 - Elsevier
Background Neutrophil extracellular traps (NETs) have been observed in the airway in
patients with chronic obstructive pulmonary disease (COPD), but their clinical and …
patients with chronic obstructive pulmonary disease (COPD), but their clinical and …
Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers
GG Einarsson, DM Comer, L McIlreavey, J Parkhill… - Thorax, 2016 - thorax.bmj.com
Rationale The role bacteria play in the progression of COPD has increasingly been highlighted
in recent years. However, the microbial community complexity in the lower airways of …
in recent years. However, the microbial community complexity in the lower airways of …
Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study
…, M Oriano, E Cant, GG Einarsson… - The lancet Respiratory …, 2021 - thelancet.com
Background Bronchiectasis is predominantly a neutrophilic inflammatory disease. There are
no established therapies that directly target neutrophilic inflammation because little is …
no established therapies that directly target neutrophilic inflammation because little is …
CAMP factor homologues in Propionibacterium acnes: a new protein family differentially expressed by types I and II
Analysis of the draft genome sequence of the opportunistic pathogen Propionibacterium acnes
type strain NCTC 737 (=ATCC 6919) revealed five genes with sequence identity to the co-…
type strain NCTC 737 (=ATCC 6919) revealed five genes with sequence identity to the co-…
CORK study in cystic fibrosis: sustained improvements in ultra-low-dose chest CT scores after CFTR modulation with ivacaftor
NJ Ronan, GG Einarsson, M Twomey, D Mooney… - Chest, 2018 - Elsevier
Background Ivacaftor produces significant clinical benefit in patients with cystic fibrosis (CF)
with the G551D mutation. Prevalence of this mutation at the Cork CF Centre is 23%. This …
with the G551D mutation. Prevalence of this mutation at the Cork CF Centre is 23%. This …
Anaerobic bacteria cultured from cystic fibrosis airways correlate to milder disease: a multisite study
MS Muhlebach, JE Hatch, GG Einarsson… - European …, 2018 - Eur Respiratory Soc
… Conflict of interest: GG Einarsson's work is supported by a grant from IMI (iABC; Inhaled
Antibiotics in Bronchiectasis and Cystic Fibrosis). N. Gotman reports grants from AECF, during …
Antibiotics in Bronchiectasis and Cystic Fibrosis). N. Gotman reports grants from AECF, during …
Characterization of bacteria using surface-enhanced Raman spectroscopy (SERS): Influence of microbiological factors on the SERS spectra
DM Allen, GG Einarsson, MM Tunney… - Analytical …, 2022 - ACS Publications
SERS is currently being explored as a rapid method for identification of bacteria but variation
in the experimental procedures has resulted in considerable variation in the spectra …
in the experimental procedures has resulted in considerable variation in the spectra …
[HTML][HTML] Extended-culture and culture-independent molecular analysis of the airway microbiota in cystic fibrosis following CFTR modulation with ivacaftor
GG Einarsson, NJ Ronan, D Mooney… - Journal of cystic …, 2021 - Elsevier
Background Treatment with Ivacaftor provides a significant clinical benefit in people with cystic
fibrosis (PWCF) with the class III G551D-CFTR mutation. This study determined the effect …
fibrosis (PWCF) with the class III G551D-CFTR mutation. This study determined the effect …
[HTML][HTML] Multi-omics approaches: the key to improving respiratory health in people with cystic fibrosis?
AJ Lee, GG Einarsson, DF Gilpin… - Frontiers in …, 2020 - frontiersin.org
The advent of high-throughput multi-omics technologies has underpinned the expansion in
lung microbiome research, increasing our understanding of the nature, complexity and …
lung microbiome research, increasing our understanding of the nature, complexity and …